Author: Bartoszewski, Rafal; Dabrowski, Michal; Jakiela, Bogdan; Matalon, Sadis; Harrod, Kevin S.; Sanak, Marek; Collawn, James F.
Title: SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs Cord-id: efwpdp3h Document date: 2020_9_1
ID: efwpdp3h
Snippet: Cold viruses have generally been considered fairly innocuous until the appearance of the severe acute respiratory coronavirus 2 (SARS-CoV-2) in 2019, which caused the coronavirus disease 2019 (COVID-19) global pandemic. Two previous viruses foreshadowed that a coronavirus could potentially have devastating consequences in 2002 [severe acute respiratory coronavirus (SARS-CoV)] and in 2012 [Middle East respiratory syndrome coronavirus (MERS-CoV)]. The question that arises is why these viruses are
Document: Cold viruses have generally been considered fairly innocuous until the appearance of the severe acute respiratory coronavirus 2 (SARS-CoV-2) in 2019, which caused the coronavirus disease 2019 (COVID-19) global pandemic. Two previous viruses foreshadowed that a coronavirus could potentially have devastating consequences in 2002 [severe acute respiratory coronavirus (SARS-CoV)] and in 2012 [Middle East respiratory syndrome coronavirus (MERS-CoV)]. The question that arises is why these viruses are so different from the relatively harmless cold viruses. On the basis of an analysis of the current literature and using bioinformatic approaches, we examined the potential human miRNA interactions with the SARS-CoV-2’s genome and compared the miRNA target sites in seven coronavirus genomes that include SARS-CoV-2, MERS-CoV, SARS-CoV, and four nonpathogenic coronaviruses. Here, we discuss the possibility that pathogenic human coronaviruses, including SARS-CoV-2, could modulate host miRNA levels by acting as miRNA sponges to facilitate viral replication and/or to avoid immune responses.
Search related documents:
Co phrase search for related documents- accession number and lung cancer: 1, 2
- active isoform and low abundance: 1
- active viral replication and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- active viral replication and adaptive innate: 1
- acute respiratory coronavirus and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory coronavirus and low abundance: 1, 2, 3, 4, 5, 6, 7
- acute respiratory coronavirus and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory coronavirus and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory coronavirus and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory coronavirus and lung inflammation damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory coronavirus and lung inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- adaptive innate and lung cancer: 1, 2, 3, 4, 5, 6, 7
- adaptive innate and lung epithelial cell: 1, 2, 3
- adaptive innate and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adaptive innate and lung inflammatory response: 1, 2, 3
- low abundance and lung cancer: 1
Co phrase search for related documents, hyperlinks ordered by date